Summary
- The government has confirmed that the current Palantir-led NHS Federated Data Platform contract will end in March 2029, rather than through its 2027 break clause.
- Formal procurement for a successor is expected to begin in the second half of 2027, with common data standards and wider supplier participation central to the plans.
- Ministers say contractual exit provisions support the transition, although MPs continue to question supplier dependence, ownership and the practical costs of migration.
The government has confirmed that the existing Palantir-led NHS Federated Data Platform contract will end in March 2029, setting out plans for a new procurement intended to give health services greater control over their technology and reduce dependence on individual suppliers.
Health innovation minister James Frith confirmed the timetable during statements to MPs on 16 and 17 November. The government has decided against using the contract’s earlier break clause, allowing the existing system to continue operating while the NHS prepares a successor based on common data standards and wider participation by technology providers.
Formal procurement is expected to begin during the second half of 2027, with ministers estimating that the process from initial engagement to completion could take approximately 18 months. The government intends to have the next generation of the platform operating when the current contract ends.
The decision establishes a clearer endpoint for the existing arrangement but leaves the future technology architecture, suppliers and final procurement requirements to be determined.
Continuity outweighs an earlier contract exit
The Federated Data Platform is intended to help NHS organisations use operational information for tasks including waiting list management, theatre planning and coordination of healthcare services. It brings together information from participating organisations without requiring every local record to be transferred into one national database.
Its software supports activities that depend on data held across different hospital and administrative systems. NHS teams can use those capabilities to examine capacity, coordinate work and identify operational opportunities, although the evidence supporting reported benefits has remained a subject of parliamentary scrutiny.
Palantir leads the consortium awarded the platform contract in 2023. The agreement included an earlier opportunity to end the arrangement in 2027, which campaigners and several MPs wanted ministers to exercise.
The government has instead chosen a longer transition. Frith argued that retaining existing services would allow the NHS to continue using the platform while procuring additional capabilities and developing the next generation of its data infrastructure.
The decision has attracted criticism from MPs concerned that continued use of Palantir could increase the difficulty of moving to another provider. Software systems become embedded in operating practices as organisations develop integrations, train staff and rely on particular applications for recurring work.
Replacing such a platform can consequently involve more than transferring data. Existing applications may need to be rebuilt or connected differently, while clinical and administrative staff require assurance that services will remain available during the change.
Ministers say these practical requirements justify the transition period. Critics argue that extending the relationship may allow the incumbent supplier to strengthen its commercial position before the replacement procurement takes place.
A different approach to NHS technology purchasing
The government wants the successor platform to use common data standards and more interoperable components, making it easier for different suppliers to contribute technology without requiring every function to depend on one company’s system.
In principle, standardised interfaces can allow an application to exchange information with another service without relying on a proprietary integration designed exclusively for one provider. Such arrangements may also make it easier to replace individual components as requirements change.
The proposed architecture would need to work with existing NHS records, analytics tools and operational systems, many of which have been developed by different suppliers over several years.
However, a commitment to interoperability does not automatically create the ability to switch providers. Contractual rights, access to technical specifications, data portability and the cost of rebuilding applications will influence whether a replacement supplier can operate the service effectively.
MPs have noted that similar commitments featured in earlier discussions surrounding the Federated Data Platform. The new procurement will therefore need to translate those principles into technical specifications and enforceable commercial requirements rather than relying on a general promise of open standards.
Ministers have also described the process as an opportunity for British technology companies, including smaller businesses, to participate in NHS digital infrastructure projects. International suppliers will remain eligible to compete, and the government has not announced a supplier selection or excluded every potential role for Palantir in future procurement.
The opportunity for domestic firms will depend on how the requirements are divided, whether suppliers can deliver distinct components and the financial and operational obligations imposed during procurement.
Exit rights face a practical test
During the 17 November debate, Frith referred to correspondence from Palantir acknowledging that the NHS has contractual exit arrangements and support intended to enable a transition to another provider at the end of the agreement.
The minister also asserted that NHS data and relevant intellectual property rights remain protected under the contractual arrangements, rejecting concerns that the NHS is permanently locked into the existing supplier.
Those assurances describe the government’s interpretation of the agreement and the position communicated by Palantir. They do not independently establish how much engineering work a transition will require or resolve every disagreement about intellectual property developed during the contract.
Ownership rights can differ between information supplied by a customer, software created specifically for a project and background technology already owned by a commercial supplier. The precise contractual terms determine which components can be reused and which would need to be licensed or replaced.
Even where the NHS retains sufficient rights to obtain its information and commission alternative software, operational migration can involve testing, redevelopment and integration with established workflows.
The procurement will also need to address cybersecurity and information governance, particularly where services process sensitive patient information or support activities spanning several healthcare organisations.
Data location is only one element of those controls. Access permissions, software administration, audit records and supplier responsibilities also influence how information is protected and how operational incidents are managed.
Clinical capabilities may expand
The government is considering additional functionality for the next generation of the platform, including work involving maternity services. Frith has identified that area as an opportunity to improve coordination and explore new digital and AI capabilities.
Those services have not been confirmed as completed deployments within a new platform. The proposed scope remains subject to development, procurement and implementation decisions.
Questions also remain about how existing functionality should be assessed before a replacement is commissioned. The NHS has published examples of operational improvements associated with the Federated Data Platform, but parliamentary scrutiny has raised concerns about adoption figures and the attribution of some claimed benefits.
Measuring the performance of individual functions would help determine which capabilities should be retained, changed or discontinued. A new procurement could otherwise preserve existing arrangements without establishing whether they offer the best available performance or value.
Techopia previously reported on the government’s consideration of continuing the Palantir arrangement before a replacement tender. The latest parliamentary statements resolve the immediate question of the contract timetable while providing a more specific route towards a successor.
The new procurement is expected to begin formally in the second half of 2027, giving the NHS a defined period to establish its requirements and assess competing approaches. With the existing contract scheduled to end in March 2029, the success of the transition will depend on whether the replacement can preserve essential services while delivering the greater interoperability and supplier choice ministers have promised.












